Trials / Completed
CompletedNCT00893659
Beta-glucan on Fecal Microflora in Polypectomized Patients
The Effect of Beta-glucan on Faecal Microflora in Polypectomized Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Harokopio University · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the effect of the potential prebiotic beta-glucan on the intestinal microflora, the bacterial enzyme activity (beta-glucuronidase and beta-glucosidase) in the feces, the fecal pH and the concentration of fecal short-chain fatty acid in polypectomized patients. Also the in vitro anti-cyto- and anti-genotoxicity of fecal water will be examined on human cell culture (HT29). During the trial, patient's clinical symptoms (intestinal habits), physical activity, well-being and food intake will be recorded.
Detailed description
Prebiotics, such as short- and long-chain fructo-oligosaccharides are fermented by the microflora colonizing the gastrointestinal tract, and they selectively stimulate the growth or the activity of one or limited number of bacteria within the intestine. Beta-glucans are polysaccharides occurring in the bran of cereal grains, the cell wall of Saccharomyces cerevisiae and bacteria, certain types of fungi, seaweed and many kinds of mushrooms. The aim of this study is to determine the effect of the potential prebiotic beta-glucan on the intestinal microflora, the bacterial enzyme activity (beta-glucuronidase and beta-glucosidase) in the faeces, the faecal pH, and the concentration of faecal short-chain fatty acid in polypectomized patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | wheat bread with beta-glucan | 3 g beta-glucan in approximately 200 g of wheat bread per day for 3 months |
| DIETARY_SUPPLEMENT | wheat bread without beta-glucan | Approximately 200 g of wheat bread (without beta-glucan supplementation) per day for 3 months |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-12-01
- Completion
- 2015-07-01
- First posted
- 2009-05-06
- Last updated
- 2015-07-24
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00893659. Inclusion in this directory is not an endorsement.